It is commonly believed that RelA:p50 mediates this pro-survival NFκB function in myeloma cells.7 Importantly, IKK inhibitors were shown to sensitize myeloma cells to apoptotic death.17, 18. This evidence concerns the gene NFKB1 and plasma cell myeloma.